Close Menu

NEW YORK — Natera on Tuesday filed with the US Securities and Exchange Commission for a follow-on public offering of its common stock worth up to $201.3 million.

The San Carlos, California-based company also said on Tuesday that it expects its third quarter revenues to be in the range of $74 million to $76 million, topping Wall Street's consensus estimate of $73.5 million. The company said it processed around 200,000 tests in the third quarter, representing approximately 20 percent growth over the year-ago quarter. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.